The Latest
Reyvow Approved for Acute Migraine Treatment
Rituximab Compared With Mycophenolate Mofetil in Pemphigus Vulgaris Trial
Xarelto Approved for Acutely Ill Medical Patients at Risk of VTE
New Treatment for Dry Eye Disease Now Available
Efficacy of Brolucizumab vs Aflibercept for Polypoidal Choroidal Vasculopathy
Onabotulinumtoxin A Investigated in Patients with Neuropathic-Like Dry Eye Without Migraine
Favorable Anatomic, Visual Outcomes With Faricimab in Neovascular Age-Related Macular Degeneration
Novel Integrin Inhibitor Meets End Point in Dry Age-Related Macular Degeneration Study
Lumacaftor-Ivacaftor Aids Cystic Fibrosis in Real-World Setting
MPR ARTICLES
